{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: Hong Kong Drug Manufacturers - Specialty & Generic news", "home_page_url": "https://sharemaestro.com/newsreel/hk/healthcare/drug-manufacturers-specialty-generic/", "feed_url": "https://sharemaestro.com/newsreel/hk/healthcare/drug-manufacturers-specialty-generic/feed.json", "description": "Latest Drug Manufacturers - Specialty & Generic company headlines from Hong Kong, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:0eaef42da0d4e28effb0572999a289bca7caadd9f74c6877cdbe43e82a4c4cbd", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPTWtTeDVfZG01bGtwYnAxOFBuM09IOElfaFplRDh0bjF1T2VNRU5qeWhtOHVHa1JteFJ6dHBBRXVzMGFBbkNDeWx5X25DNWxMa3VXNXl6cDlyZ3B6TmFibGlySkZUaXRIa1VfLUpycWtNanZFT2ZoXy1YekRCMzhIUmpGTzVjQkdfY3UwZmZwbGpJcVEzQ29aX3JTN2NoUTMxNWJiX2U1VHZBLWNoc0RpU29nZjNfbG9FeU9hY0RFcDRxeE8zaDk0c05GYUs5VWVVQXp3?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPTWtTeDVfZG01bGtwYnAxOFBuM09IOElfaFplRDh0bjF1T2VNRU5qeWhtOHVHa1JteFJ6dHBBRXVzMGFBbkNDeWx5X25DNWxMa3VXNXl6cDlyZ3B6TmFibGlySkZUaXRIa1VfLUpycWtNanZFT2ZoXy1YekRCMzhIUmpGTzVjQkdfY3UwZmZwbGpJcVEzQ29aX3JTN2NoUTMxNWJiX2U1VHZBLWNoc0RpU29nZjNfbG9FeU9hY0RFcDRxeE8zaDk0c05GYUs5VWVVQXp3?oc=5", "title": "Sihuan Pharmaceutical Sets Board Meeting to Approve Interim Results and Dividend Plan", "content_text": "Sihuan Pharmaceutical Sets Board Meeting to Approve Interim Results and Dividend Plan", "date_published": "2026-08-14T09:43:54+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Earnings", "0460"], "_sharemaestro": {"country": "Hong Kong", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "0460", "name": "Sihuan Pharmaceutical Holdings Group Ltd.", "sentiment_url": "https://sharemaestro.com/sentiment/cc0cd905-09d4-46cf-ad96-96a638ddc895/"}]}}, {"id": "source:72a93b842e4e544bc0e08061b04e638ca9eac2128df13fc46f2ba86745daf29c", "url": "https://finance.yahoo.com/healthcare/articles/beyang-closes-oversubscribed-30-million-093800024.html", "external_url": "https://finance.yahoo.com/healthcare/articles/beyang-closes-oversubscribed-30-million-093800024.html", "title": "Beyang Closes Oversubscribed $30 Million Series A Financing", "content_text": "Funding to accelerate the iteration of the proprietary AI-driven ExCEED platform and advance global clinical development of differentiated pipelines, including a second-generation Menin inhibitor and a novel ophthalmic therapy. CHENGDU, China, Aug. 12, 2026 /PRNewswire/ -- Beyang Therapeutics Co., Ltd. (\"Beyang\"), an AI-driven innovative drug R&D company dedicated to building a \"DreamWorks\" for innovative drug discovery, today announced the successful closing of an oversubscribed Series A financing round, raising nearly $30 million. The round was co-led by Legend Capital and Shanghai Healthcar", "date_published": "2026-08-12T09:38:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "0867"], "_sharemaestro": {"country": "Hong Kong", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "0867", "name": "China Medical System Holdings Limited", "sentiment_url": "https://sharemaestro.com/sentiment/4bf4d06a-3706-42b1-a96d-12a632d079b8/"}]}}, {"id": "source:cdfc7b2fe3e024ac9fdfd448118f679ce529c4083bc0e0c6fbdd0111201bb61d", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPZWoxUDBNbmxKRkRBUmRXTXhreGpDYkg1eVgtZnR5Wm1ZVU1Wd2lvZk9lei0wVTF0b2xwdnBOTnBRTHFfYTMyeEZEaFJiNEdiNFllRE5RNG9mWEUyMUtyWDNLeWl2SHIzRm9NaXhJYVJ0M0pFUTh4aUwyS1JOWG9TN2FSS1Ztd0VRTTVtS1JVLVhrZEZPTk02THhKeTZIM0ZjbDdCa2lSWUY3N0FRbWYxY1VPT0Z3SWN3Y2FQTkNOcw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPZWoxUDBNbmxKRkRBUmRXTXhreGpDYkg1eVgtZnR5Wm1ZVU1Wd2lvZk9lei0wVTF0b2xwdnBOTnBRTHFfYTMyeEZEaFJiNEdiNFllRE5RNG9mWEUyMUtyWDNLeWl2SHIzRm9NaXhJYVJ0M0pFUTh4aUwyS1JOWG9TN2FSS1Ztd0VRTTVtS1JVLVhrZEZPTk02THhKeTZIM0ZjbDdCa2lSWUY3N0FRbWYxY1VPT0Z3SWN3Y2FQTkNOcw?oc=5", "title": "Jiangsu Hengrui Board to Review Interim Results and Dividend in August", "content_text": "Jiangsu Hengrui Board to Review Interim Results and Dividend in August", "date_published": "2026-08-06T09:48:51+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Earnings", "1276"], "_sharemaestro": {"country": "Hong Kong", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "1276", "name": "Jiangsu Hengrui Pharmaceuticals Co.,Ltd", "sentiment_url": "https://sharemaestro.com/sentiment/ca68c8a2-725f-4a56-a3bf-cfc839500ac8/"}]}}, {"id": "source:56fbf67c95b395e9e783f14d949422d24f3d366568b9ac3fd516a9411144a702", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNYk9qUzdlT051ekhNZmhjOHRpUUZrQ3ItTmhmbGJCTmJjaWdhUXNVSDlBNHhBdDItMDZVLTl0MS04UDFhUVVtdEpqMlRsaE5yS0VNcktKMTM4bjhuWDdZRVpudlFYOUVjby1vdk9lMWFGT3ZpN29hOU1pdEVaRDFDaTJQVERhQ1RueE80Q2liLW9ST21oRmVvQnhOOEdrMEVzVlhyekdXd2xtZXhGWXdJQk5LMFEteXRSQmd3STdB?oc=5", "external_url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNYk9qUzdlT051ekhNZmhjOHRpUUZrQ3ItTmhmbGJCTmJjaWdhUXNVSDlBNHhBdDItMDZVLTl0MS04UDFhUVVtdEpqMlRsaE5yS0VNcktKMTM4bjhuWDdZRVpudlFYOUVjby1vdk9lMWFGT3ZpN29hOU1pdEVaRDFDaTJQVERhQ1RueE80Q2liLW9ST21oRmVvQnhOOEdrMEVzVlhyekdXd2xtZXhGWXdJQk5LMFEteXRSQmd3STdB?oc=5", "title": "Wai Yuen Tong Gains Listing Rule Waiver for Delayed Disposal Circular", "content_text": "Wai Yuen Tong Gains Listing Rule Waiver for Delayed Disposal Circular", "date_published": "2026-07-31T10:44:49+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "0897"], "_sharemaestro": {"country": "Hong Kong", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "0897", "name": "Wai Yuen Tong Medicine Holdings Limited", "sentiment_url": "https://sharemaestro.com/sentiment/f9b9741f-97e9-4e2a-bc83-7c54bffc7d68/"}]}}, {"id": "source:d206e5145be44b76138d8336571bec8b2896e753b299f1af423dd75620d0c5f9", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxQTm1nUVV4MHVOOUdjUU93OThHN1d4elQ5QkZBa1ozMmVmaTZiMkx1R0t6c3BlZjlvdnpYRFZVSEtjV18xYjJZYzhPZmw2RDJEY3U4OUlucHVTYVNVcGg0bUV2X04tNjlsdXVBWDc5b3JTandrZXREeHdFWUwzaW5HYW5RcGxSYlBJVmFMbTlvWWFCY2FVaXJIc0daMF8tWmJQWDg0YXVfNUxCSktES0FnY1c5ODZWOEIwemI5R3pxb1AzejdGejVmOGtlY1dLdDZJOTJ0eEQ1VHFIeGxaQjBpQWtsMElkVkgwejNMTDJNWi1ENUwx?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxQTm1nUVV4MHVOOUdjUU93OThHN1d4elQ5QkZBa1ozMmVmaTZiMkx1R0t6c3BlZjlvdnpYRFZVSEtjV18xYjJZYzhPZmw2RDJEY3U4OUlucHVTYVNVcGg0bUV2X04tNjlsdXVBWDc5b3JTandrZXREeHdFWUwzaW5HYW5RcGxSYlBJVmFMbTlvWWFCY2FVaXJIc0daMF8tWmJQWDg0YXVfNUxCSktES0FnY1c5ODZWOEIwemI5R3pxb1AzejdGejVmOGtlY1dLdDZJOTJ0eEQ1VHFIeGxaQjBpQWtsMElkVkgwejNMTDJNWi1ENUwx?oc=5", "title": "UBS Keeps Their Buy Rating on Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276)", "content_text": "UBS Keeps Their Buy Rating on Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276)", "date_published": "2026-07-28T07:00:00+00:00", "authors": [{"name": "The Globe and Mail"}], "tags": ["Analyst action", "1276"], "_sharemaestro": {"country": "Hong Kong", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "1276", "name": "Jiangsu Hengrui Pharmaceuticals Co.,Ltd", "sentiment_url": "https://sharemaestro.com/sentiment/ca68c8a2-725f-4a56-a3bf-cfc839500ac8/"}]}}]}